FDA Notifies Congress of the Proposed Regulatory Oversight of Laboratory Developed Tests

On July 31, 2014, the U.S. Food and Drug Administration (FDA or the Agency) announced plans to formally regulate laboratory developed tests (LDTs). The announcement came in the form of letters to Congress attaching the preliminary drafts of two guidance documents describing the Agency's proposed risk-based framework for regulatory oversight of LDTs.

Read More: FDA Notifies Congress of the Proposed Regulatory Oversight of Laboratory Developed Tests


Download PDF Share Back To Listing
Loading data